NCT03627897View on ClinicalTrials.gov

ESP Block in Pediatric Patients for Postoperative Analgesia

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

March 1, 2021

Study Completion Date

April 1, 2021

Conditions
Opioid UsePain, PostoperativeQuality of Life
Interventions
DRUG

Bupivacain

The erector spinae plane blocks proceed with 0,5 ml/kg of 0,25% bupivacain (Group B).

DRUG

saline

No drugs or interventions were administered to the control group.

Trial Locations (1)

01330

Feri̇de Karacaer, Adana

All Listed Sponsors
lead

Cukurova University

OTHER

NCT03627897 - ESP Block in Pediatric Patients for Postoperative Analgesia | Biotech Hunter | Biotech Hunter